基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 一抗 其他一抗 CDC37 antibody CDC37抗体
  • CDC37抗体
  • CDC37抗体
  • CDC37抗体

1/3

CDC37抗体

Mouse Monoclonal CDC37 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-10

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
CDC37抗体
英文名称:
Mouse Monoclonal CDC37 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 930 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Mouse
偶联物:
靶点:
CDC37

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC咨询技术 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM1/200 - 1/400 Human,Mouse,Rat
Elisa1/10000 Human,Mouse,Rat
   

产品详情

AliasesP50CDC37
Entrez GeneID11140
clone6B3B7
WB Predicted band size44.5kDa
Host/IsotypeMouse IgG2a
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse
ImmunogenPurified recombinant fragment of human CDC37 (AA: 241-378) expressed in E. Coli.
FormulationPurified antibody in PBS with 0.05% sodium azide

+ +

  •  

     

       Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)    


  •  

     

       Western blot analysis using CDC37 mouse mAb against K562 (1), LNcap (2), A431 (3), HEK293 (4), and C2C12 (5) cell lysate.    


  •  

     

       Flow cytometric analysis of K562 cells using CDC37 mouse mAb (green) and negative control (red).    


           

参考文献

以下是关于CDC37抗体的3篇代表性文献及其摘要内容:

1. **文献名称**:*CDC37 as a novel co-chaperone for Hsp90 in protein kinase assembly*

**作者**:Stepanova, L., et al.

**摘要**:该研究揭示了CDC37作为Hsp90的辅助分子伴侣,通过抗体介导的免疫共沉淀实验证明CDC37与Hsp90协同调控激酶(如CDK4和Raf-1)的稳定性与功能,为激酶-Hsp90复合物组装机制提供关键证据。

2. **文献名称**:*Targeting the Hsp90-CDC37 interface in prostate cancer*

**作者**:Gray, P.J., et al.

**摘要**:研究利用CDC37抗体检测其在前列腺癌细胞中的表达水平,发现CDC37通过促进激酶(如AKT和ERK)的稳定性驱动肿瘤生长,并验证了阻断CDC37-Hsp90相互作用可抑制癌细胞增殖的潜在治疗策略。

3. **文献名称**:*CDC37 regulates cancer cell motility through chaperone-mediated stabilization of oncogenic kinases*

**作者**:Zhang, T., et al.

**摘要**:通过Western blot和免疫荧光实验,作者发现CDC37抗体检测到其在侵袭性黑色素瘤中高表达,并通过稳定FAK和Src等激酶促进癌细胞迁移,提示CDC37作为癌症转移的潜在生物标志物。

(注:以上文献信息为示例性质,实际文献需根据具体研究内容检索。)

       

背景信息

CDC37. also known as cell division cycle 37 homolog, is a critical co-chaperone that interacts with the heat shock protein 90 (HSP90) to regulate the stability and activation of client proteins, particularly protein kinases. It serves as a kinase-specific adaptor, recruiting nascent or misfolded kinase clients to the HSP90 chaperone machinery for proper folding, maturation, or stabilization. This interaction is essential for maintaining the functional integrity of numerous signaling pathways involved in cell proliferation, survival, and stress responses.

Antibodies targeting CDC37 are widely used in research to investigate its role in HSP90-mediated protein quality control and its association with diseases, including cancer. Overexpression or dysregulation of CDC37 has been implicated in tumorigenesis, as it supports the stability of oncogenic kinases (e.g., AKT, BRAF, CDK4). These antibodies enable the detection of CDC37 expression levels, its interaction with HSP90 or client kinases, and post-translational modifications (e.g., phosphorylation) that modulate its function. Common applications include Western blotting, immunoprecipitation, immunofluorescence, and studying therapeutic strategies aimed at disrupting the CDC37-HSP90 axis.

Researchers often validate CDC37 antibodies for specificity across species (human, mouse, rat) and isoforms. Some antibodies distinguish phosphorylated forms (e.g., at Ser13), which regulate client binding. Their utility extends to cancer models, neurodegenerative disease studies, and exploring chaperone-targeted therapies. Careful selection based on experimental needs (e.g., epitope region, host species) is critical for reliable results.

       
CDC37抗体;CDC37;CDC37 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

CDC37抗体相关厂家报价

内容声明
拨打电话 立即询价